Spruce Biosciences Inc
NASDAQ:SPRB

Watchlist Manager
Spruce Biosciences Inc Logo
Spruce Biosciences Inc
NASDAQ:SPRB
Watchlist
Price: 83.4 USD -5.67% Market Closed
Market Cap: 89.3m USD

Wall Street
Price Targets

SPRB Price Targets Summary
Spruce Biosciences Inc

Wall Street analysts forecast SPRB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SPRB is 213.69 USD with a low forecast of 161.6 USD and a high forecast of 271.95 USD.

Lowest
Price Target
161.6 USD
94% Upside
Average
Price Target
213.69 USD
156% Upside
Highest
Price Target
271.95 USD
226% Upside
Spruce Biosciences Inc Competitors:
Price Targets
SYNACT
SynAct Pharma AB
28% Upside
ANAB
AnaptysBio Inc
37% Upside
KURA
Kura Oncology Inc
229% Upside
MIRM
Mirum Pharmaceuticals Inc
38% Upside
302440
SK Bioscience Co Ltd
25% Downside
AMRN
Amarin Corporation PLC
15% Downside
1801
Innovent Biologics Inc
26% Upside
ATX
Amplia Therapeutics Ltd
230% Upside

Revenue
Forecast

Revenue Estimate
Spruce Biosciences Inc

The compound annual growth rate of Spruce Biosciences Inc's revenue for the next 3 years is 28%.

N/A
Past Growth
28%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Spruce Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Net Income
Forecast

Net Income Estimate
Spruce Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-72%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SPRB's stock price target?
Price Target
213.69 USD

According to Wall Street analysts, the average 1-year price target for SPRB is 213.69 USD with a low forecast of 161.6 USD and a high forecast of 271.95 USD.

What is Spruce Biosciences Inc's Revenue forecast?
Projected CAGR
28%

The compound annual growth rate of Spruce Biosciences Inc's revenue for the next 3 years is 28%.

Back to Top